Conferences & Events

Found 83,700 articles

• AMCP Foundation Semiannual Best Poster Competition Virtually Illustrates the Financial Impact of Managed Care Pharmacy Strategies

  10/23/2020

  AMCP Foundation hosted its most recent Best Poster Competition at AMCP Nexus 2020 Virtual on Wednesday, Oct. 21.

• Prime Minister announces funding to advance the development of Canadian COVID-19 vaccine technologies

  10/23/2020

  As we continue to address the health, social, and economic impacts of COVID-19, the Government of Canada is actively pursuing the purchase and development of vaccines, treatments, and related supplies to protect Canadians from the virus and support our recovery from the pandemic

• ATW Tech provides an update on the private placement and the acquisition of Semeon Analytics Inc.

  10/23/2020

  ATW Tech Inc. (the "Company" or "ATWTech") (TSX-V: ATW) provides an update on the acquisition of Semeon Analytics Inc. (the "Acquisition") and the private placement (the "Private Placement") that were announced on October 1, 2020. ATW Tech has decided to postpone the estimated closing date of the Acquisition and the Private Placement in order to complete the due diligence of Semeon Analytics Inc.

• XORTX Reports Annual & Special Meeting Results

  10/23/2020

  XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the results of the Company’s 2020 Annual and Special Meeting of Shareholders held today.

• Brickell Biotech Announces Pricing of $15.0 Million Underwritten Public Offering

  10/23/2020

  Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced the pricing of an underwritten public offering of 20,833,322 shares of common stock or common stock equivalents

• Sun Nuclear Presents Updated & Comprehensive Quality Management Solutions at 2020 ASTRO Annual Meeting

  10/23/2020

  During the 2020 ASTRO Annual Meeting, taking place online October 23-29, Sun Nuclear is highlighting a range of solutions clinics can leverage to ensure continuity for their Quality Management programs.

• Top Minds in Emergency Medical Research Gather for ACEP20 Research Forum

  10/23/2020

  Leading emergency medicine researchers will be on hand for the American College of Emergency Physicians (ACEP) Research Forum, part of ACEP20, the world's largest emergency medicine conference

• Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting

  10/23/2020

  Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced upcoming poster presentations at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 2020 Annual Meeting, being held virtually November 1-7.

• Pneuma Introduces the First Anti-Aging Serum that Corrects Wrinkles at the Source of Aging - N1o1

  10/23/2020

  World renowned Biochemist, Dr. Nathan S. Bryan introduces N1o1, the first anti-aging skincare that uses a Nobel Prize winning discovery to defy aging skin by correcting the cause of wrinkled and damaged skin plus age spots and blemish prone skin

• Randomized Control Trial Demonstrates Untire is an Effective Digital Therapeutic Against Cancer Fatigue

  10/23/2020

  The University of Groningen announces the publication of their International Waiting-list Randomized Controlled Trial (RCT) assessing the efficacy of Untire in the Journal of Psycho-Oncology.

• PharmAbcine to participate at BIO-Europe 2020

  10/23/2020

  PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will participate in the 26th Annual International BIO-Europe Partnering Conference which will be held digitally from October 26th to 29th.

• Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in Europe

  10/23/2020

  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the European Commission (EC) has granted Orphan Designation to TransCon PTH for the treatment of hypoparathyroidism (HP).

• Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2020 Financial and Operational Results on November 6, 2020

  10/23/2020

  Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Friday, November 6, 2020 at 8:30 a.m. ET to discuss operational and financial results for the third quarter ended September 30, 2020.

• Invitation to the Sobi Capital Markets Day 2020

  10/23/2020

  Save the date for Swedish Orphan Biovitrum AB Capital Markets Day on 10 December 2020.

• BerGenBio Virtual R&D Day - 06 November 2020

  10/23/2020

  BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, is pleased to announce that it will host a virtual R&D Day on 06 November 2020 from 13.00 CET.

• The Ensign Group Schedules Third Quarter 2020 Earnings Call for Thursday, October 29, 2020

  10/23/2020

  The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign (TM) group of companies, which provide skilled nursing services, senior living services, rehabilitative care services and other healthcare services, announced today that it expects to issue its third quarter 2020 financial results on Wednesday, October 28, 2020. Conference Call Ensign invites current and prospective investors to tune into a live webcast

• Taiho Oncology Launches World of Hope Campaign to Support MDS World Awareness Day

  10/23/2020

   Taiho Oncology, Inc., today announced the launch of its World of Hope campaign to support patients living with myelodysplastic syndrome (MDS) and bring much-needed attention to this rare and difficult-to-treat cancer during MDS World Awareness Day on October 25, 2020 . MDS is a rare blood cancer that impacts approximately 4 to 5

• HFC Raises Over $325K and Connects Over 2000 Supporters for Alzheimer's Awareness During First Virtual Game Show, Hosted by Seth Rogen

  10/23/2020

  National Alzheimer's Nonprofit Takes Annual Fundraising Virtual With Celebrity-Hosted, 70s-Themed Game Show Featuring Elizabeth Banks, Anna Faris, Jim Gaffigan, Billy Eichner and Craig Robinson.

• New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status

  10/23/2020

  - Jardiance (empagliflozin) reduced risk for the composite endpoint of cardiovascular death and hospitalization for heart failure, as well as serious adverse kidney outcomes, in adults with or without chronic kidney disease at baseline. The trial included people with and without diabetes - Sub-analysis findings from the EMPEROR-Reduced phase III trial were presented at the American Society of Nephrology Kidney Week 2020

• Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5

  10/23/2020

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the fiscal 2020 third quarter ended September 30, 2020 on Thursday, Nov